HGA IFA - IgG

Optimal result: 0 – 40 titer

Anaplasmosis is a tick-borne infection that can sometimes be severe or fatal. Anaplasmosis is caused by the bacteria, Anaplasma phagocytophilum. It cannot be spread from person-to-person. You may develop anaplasmosis if you are bitten by an infected blacklegged tick.

A positive result in the HGA (Human Granulocytic Anaplasmosis) IFA - IgG test indicates that the patient's blood contains IgG antibodies against Anaplasma phagocytophilum, the bacterium that causes Human Granulocytic Anaplasmosis. This typically suggests that the individual has been exposed to the bacterium, either through a past infection or a current ongoing one. IgG antibodies are part of the immune system's response to an infection and usually develop a few weeks after the initial exposure, often remaining in the bloodstream for a long duration. Their presence can indicate either a past exposure to Anaplasma phagocytophilum, where the infection has been resolved, or a chronic, ongoing infection. However, a positive IgG test alone does not necessarily mean an active infection is present, especially if the individual shows no current symptoms of Anaplasmosis, like fever, muscle aches, or fatigue.

For treatment, if symptoms of Anaplasmosis are present and the test result is positive, the standard approach is to treat with the antibiotic doxycycline. Doxycycline is effective against Anaplasma phagocytophilum and is typically prescribed for 10-14 days, depending on the severity of the symptoms and the patient’s response to therapy. It is important to start treatment as soon as possible, especially if symptoms are severe, to prevent complications. In cases where Anaplasmosis is strongly suspected or confirmed based on a positive IgG result, and the patient has symptoms, prompt treatment with doxycycline is recommended. In asymptomatic individuals with a positive IgG result, further evaluation and monitoring might be necessary to determine the need for treatment. As always, clinical symptoms and patient history should be considered alongside laboratory results for a comprehensive assessment and management plan.

Anaplasmosis is a tick-borne infection that can sometimes be severe or fatal. Anaplasmosis is caused by the bacteria, Anaplasma phagocytophilum. It cannot be spread from person-to-person. You may develop anaplasmosis if you are bitten by an infected blacklegged tick.

---------------

An "Indeterminate" result (where result falls in the "orange" reference range) on an HGA IFA - IgG test, suggests that the detected levels of IgG antibodies are neither clearly positive nor negative. This ambiguous result can occur in various scenarios, such as during the early stages of infection when antibody levels are rising, during the resolution phase of a past infection when antibody levels are declining, or due to cross-reactivity with antibodies from similar infections. It poses interpretation challenges and often necessitates further evaluation considering the clinical context, including symptoms and history of tick exposure. In some cases, repeat testing after a period may be required to monitor changes in antibody levels, thereby aiding in clarifying the diagnosis. This indeterminate result highlights the complexity of diagnosing anaplasmosis solely based on serological testing and underscores the need for a comprehensive clinical assessment.

Anaplasmosis is a tick-borne infection that can sometimes be severe or fatal. Anaplasmosis is caused by the bacteria, Anaplasma phagocytophilum. It cannot be spread from person-to-person. You may develop anaplasmosis if you are bitten by an infected blacklegged tick.

The HGA (Human Granulocytic Anaplasmosis) IFA (Indirect Fluorescent Antibody) - IgG test, included in an Anaplasmosis panel, is a serological assay designed to detect Immunoglobulin G (IgG) antibodies specific to Anaplasma phagocytophilum, the causative agent of Human Granulocytic Anaplasmosis, a tick-borne disease. This test is crucial for the diagnosis and epidemiological study of Anaplasmosis, particularly in assessing past exposure or monitoring the immune response over time. IgG antibodies represent a later stage of the immune response, typically developing a few weeks after initial exposure to the pathogen and persisting in the bloodstream for a prolonged duration, often for years. In the HGA IFA - IgG test, patient serum is incubated with antigen-coated slides containing A. phagocytophilum, allowing any specific IgG antibodies present to bind to these antigens. This binding is then visualized under a microscope using a fluorescently-labeled secondary antibody that specifically attaches to human IgG, providing both qualitative and semi-quantitative data about the antibody levels. A reactive IgG test indicates previous exposure to A. phagocytophilum and can be a marker of past or chronic infection. However, it's important to note that a positive IgG result does not necessarily imply an active, ongoing infection, as these antibodies can remain long after the infection has resolved. Therefore, the results of the HGA IFA - IgG test should be interpreted in the context of the patient's clinical symptoms, history of tick exposure, and other laboratory findings, including IgM serology and PCR testing, for a comprehensive assessment of the patient’s Anaplasmosis status. This test is instrumental in the clinical diagnosis and management of suspected Anaplasmosis cases, guiding appropriate treatment and follow-up.

HGA IFA - IgG
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond HGA IFA - IgG — 10,000+ markers explained
One HGA IFA - IgG result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro